These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 8500080

  • 21. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [Abstract] [Full Text] [Related]

  • 23. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.
    Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF.
    Biol Psychiatry; 1996 Sep 01; 40(5):382-8. PubMed ID: 8874839
    [Abstract] [Full Text] [Related]

  • 24. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR, Fawcett J, Zajecka JM.
    J Clin Psychiatry; 1993 Oct 01; 54(10):380-4. PubMed ID: 8262880
    [Abstract] [Full Text] [Related]

  • 25. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients.
    Calabrese JR, Markovitz PJ, Kimmel SE, Wagner SC.
    J Clin Psychopharmacol; 1992 Feb 01; 12(1 Suppl):53S-56S. PubMed ID: 1541718
    [Abstract] [Full Text] [Related]

  • 26. [Predictors of response to phase prophylactics (mood stabilizers) in bipolar affective disorders].
    Walden J, Normann C, Langosch J, Grunze H.
    Fortschr Neurol Psychiatr; 1999 Feb 01; 67(2):75-80. PubMed ID: 10093780
    [Abstract] [Full Text] [Related]

  • 27. Treatment of bipolar disorder.
    Mitchell PB, Parker GB.
    Med J Aust; 1991 Oct 07; 155(7):488-93. PubMed ID: 1921822
    [Abstract] [Full Text] [Related]

  • 28. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT.
    Can J Psychiatry; 1993 Apr 07; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [Abstract] [Full Text] [Related]

  • 29. Polypharmacy in bipolar I disorder.
    Solomon DA, Keitner GI, Ryan CE, Miller IW.
    Psychopharmacol Bull; 1996 Apr 07; 32(4):579-87. PubMed ID: 8993078
    [Abstract] [Full Text] [Related]

  • 30. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC.
    Encephale; 2001 Apr 07; 27(3):277-9. PubMed ID: 11488258
    [Abstract] [Full Text] [Related]

  • 31. Psychosensory symptoms in bipolar disorder.
    Ali SO, Denicoff KD, Ketter TA, Smith-Jackson EE, Post RM.
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct 07; 10(4):223-31. PubMed ID: 9359118
    [Abstract] [Full Text] [Related]

  • 32. Treatment of rapid-cycling bipolar disorder.
    Schneck CD.
    J Clin Psychiatry; 2006 Oct 07; 67 Suppl 11():22-7. PubMed ID: 17029493
    [Abstract] [Full Text] [Related]

  • 33. Anticonvulsants in bipolar disorder.
    Singh V, Muzina DJ, Calabrese JR.
    Psychiatr Clin North Am; 2005 Jun 07; 28(2):301-23. PubMed ID: 15826734
    [Abstract] [Full Text] [Related]

  • 34. Bipolar rapid cycling: focus on depression as its hallmark.
    Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ.
    J Clin Psychiatry; 2001 Jun 07; 62 Suppl 14():34-41. PubMed ID: 11469674
    [Abstract] [Full Text] [Related]

  • 35. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Jun 07; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 36. Emerging perspectives on valproate in affective disorders.
    Post RM.
    J Clin Psychiatry; 1989 Mar 07; 50 Suppl():3-9. PubMed ID: 2494156
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA, Hirschfeld RM, Ahearn EP, Weisler RH, Palmer C, Keck PE.
    J Affect Disord; 2005 Jun 07; 86(2-3):183-93. PubMed ID: 15935238
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.
    J Affect Disord; 2008 Aug 07; 109(3):251-63. PubMed ID: 18579216
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of bipolar disorder: how far have we come?
    Hopkins HS, Gelenberg AJ.
    Psychopharmacol Bull; 1994 Aug 07; 30(1):27-38. PubMed ID: 7972626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.